The CALM-CAH Phase 3 study is a randomized, placebo-controlled trial evaluating atumelnant in adults with classic CAH, designed to assess reductions in excess androgens, improvements in glucocorticoid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback